Indian Journal of PsychiatryIndian Journal of Psychiatry
Home | About us | Current Issue | Archives | Ahead of Print | Submission | Instructions | Subscribe | Advertise | Contact | Login 
    Users online: 1540 Small font sizeDefault font sizeIncrease font size Print this article Email this article Bookmark this page
Read this article

 


    Article Cited by others

ORIGINAL ARTICLE

Evaluation of antioxidant deficit in schizophrenia

Dadheech Gora, Mishra Sandhya, Gautam Shiv, Sharma Praveen

Year : 2008| Volume: 50| Issue : 1 | Page no: 16-20

   This article has been cited by
 
1 Active ribosomal genes, translational homeostasis and oxidative stress in the pathogenesis of schizophrenia and autism
Lev N. Porokhovnik,Vladimir P. Passekov,Nataliya L. Gorbachevskaya,Alexander B. Sorokin,Nataliya N. Veiko,Nataliya A. Lyapunova
Psychiatric Genetics. 2015; 25(2): 79
[Pubmed]  [Google Scholar] [DOI]
2 Omega-3 prevents behavior response and brain oxidative damage in the ketamine model of schizophrenia
A.I. Zugno,H.L. Chipindo,A.M. Volpato,J. Budni,A.V. Steckert,M.B. de Oliveira,A.S. Heylmann,F. da Rosa Silveira,G.A. Mastella,S.G. Maravai,P.G. Wessler,A.R. Binatti,B. Panizzutti,P.F. Schuck,J. Quevedo,C.S. Gama
Neuroscience. 2014; 259: 223
[Pubmed]  [Google Scholar] [DOI]
3 Oxidative stress, rRNA genes, and antioxidant enzymes in pathogenesis of schizophrenia and autism: Modeling and clinical recommendations
L. N. Porokhovnik,V. P. Pasekov,N. A. Yegolina,T. G. Tzvetkova,N. V. Kosyakova,N. L. Gorbachevskaya,N. K. Sukhotina,G. V. Kozlovskaya,A. B. Sorokin,N. Yu. Korovina,N. A. Lyapunova
Biology Bulletin Reviews. 2014; 4(5): 363
[Pubmed]  [Google Scholar] [DOI]
4 The Effects of Ziprasidone, Clozapine and Haloperidol on Lipid Peroxidation in Human Plasma (in vitro): Comparison
Anna Dietrich-Muszalska,Justyna Kopka,Anna Kwiatkowska
Neurochemical Research. 2013; 38(7): 1490
[Pubmed]  [Google Scholar] [DOI]
5 Vitamin C in Disease Prevention and Cure: An Overview
Shailja Chambial,Shailendra Dwivedi,Kamla Kant Shukla,Placheril J. John,Praveen Sharma
Indian Journal of Clinical Biochemistry. 2013; 28(4): 314
[Pubmed]  [Google Scholar] [DOI]
6 Reduced total antioxidant level and increased oxidative stress in patients with deficit schizophrenia: A preliminary study
Yakup Albayrak,Cüneyt Ünsal,Murat Beyazyüz,Ahmet Ünal,Murat Kuloglu
Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2013; 45: 144
[Pubmed]  [Google Scholar] [DOI]
7 Changes in oxidative stress markers in patients with schizophrenia: The effect of antipsychotic drugs
Meng-Chang Tsai,Chia-Wei Liou,Tsu-Kung Lin,I-Mei Lin,Tiao-Lai Huang
Psychiatry Research. 2013; 209(3): 284
[Pubmed]  [Google Scholar] [DOI]
8 Meta-Analysis of Oxidative Stress in Schizophrenia
Joshua Flatow,Peter Buckley,Brian J. Miller
Biological Psychiatry. 2013; 74(6): 400
[Pubmed]  [Google Scholar] [DOI]
9 Possible pathophysiological mechanisms of changes in several cytokines and in the lipid peroxidation and antioxidant defense system in first-episode schizophrenia patients
N. V. Ozornina,A. S. Ozornin,N. V. Govorin
Neurochemical Journal. 2013; 7(3): 230
[Pubmed]  [Google Scholar] [DOI]
10 Sex differences in lipid peroxidation and fatty acid levels in recent onset schizophrenia
Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2013; 44: 154
[HTML Full text]  [Google Scholar] [DOI]
11 Inter-relationship of plasma markers of oxidative stress and thyroid hormones in schizophrenics
Moses O Akiibinu, Omobola A Ogundahunsi, Ebenezer O Ogunyemi
BMC Research Notes. 2012; 5(1): 169
[HTML Full text]  [Google Scholar] [DOI]
12 Antioxidant defense system and family environment in adolescents with family history of psychosis
Ana Gonzalez-Pinto,Monica Martinez-Cengotitabengoa,Celso Arango,Immaculada Baeza,Soraya Otero-Cuesta,Montserrat Graell-Berna,César Soutullo,Juan Leza,Juan Micó
BMC Psychiatry. 2012; 12(1): 200
[Pubmed]  [Google Scholar] [DOI]
13 Oxidative Stress-Induced Response of Some Endogenous Antioxidants in Schizophrenia
Gora Dadheech, Praveen Sharma, Shiv Gautam
Indian Journal of Clinical Biochemistry. 2012;
[HTML Full text]  [Google Scholar] [DOI]
14 The reduction of superoxide dismutase activity is associated with the severity of neurological soft signs in patients with schizophrenia
Monia Raffa,Chiraz Fendri,Leila Ben Othmen,Héla Slama,Montassar Amri,Abdelhamid Kerkeni,Anwar Mechri
Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2012; 39(1): 52
[Pubmed]  [Google Scholar] [DOI]
15 The Relationship Between Serum Uric Acid Concentration and Metabolic Syndrome in Patients With Schizophrenia or Schizoaffective Disorder
Chih-Chiang Chiu,Chun-Hsin Chen,Ming-Chyi Huang,Po-Yu Chen,Chang-Jer Tsai,Mong-Liang Lu
Journal of Clinical Psychopharmacology. 2012; 32(5): 585
[Pubmed]  [Google Scholar] [DOI]
16 Increased Oxidant Stress and Inflammation in Patients with Chronic Schizophrenia
Aysenur Yegin,Nurullah Ay,Ozgur Aydin,Nedim Yargici,Esin Eren,Necat Yilmaz
International Journal of Clinical Medicine. 2012; 03(05): 368
[Pubmed]  [Google Scholar] [DOI]
17 Viral infection, inflammation and schizophrenia
Rachel E. Kneeland, S. Hossein Fatemi
Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2012;
[HTML Full text]  [Google Scholar] [DOI]
18 Oxidative stress in schizophrenia: An integrated approach
Byron K.Y. Bitanihirwe, Tsung-Ung W. Woo
Neuroscience & Biobehavioral Reviews. 2011; 35(3): 878
[HTML Full text]  [Google Scholar] [DOI]
19 Elevated plasma superoxide dismutase in first-episode and drug naive patients with schizophrenia: Inverse association with positive symptoms
Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2011;
[HTML Full text]  [Google Scholar] [DOI]
20 Antioxidants, Redox Signaling, and Pathophysiology in Schizophrenia: An Integrative View
Jeffrey K. Yao, Matcheri S. Keshavan
Antioxidants and Redox Signaling. 2011; 15(7): 2011
[HTML Full text]  [Google Scholar] [DOI]
21 Evaluation of antioxidant enzymes activities and lipid peroxidation in schizophrenic patients treated with typical and atypical antipsychotics
Manuela Padurariu, Alin Ciobica, Irina Dobrin, Cristinel Stefanescu
Neuroscience Letters. 2010; 479(3): 317
[HTML Full text]  [Google Scholar] [DOI]
22 The implications of medication development in the treatment of substance use disorders in developing countries
Jagadisha Thirthalli, Prabhat K Chand
Current Opinion in Psychiatry. 2009; 22(3): 274
[HTML Full text]  [Google Scholar] [DOI]
23 Study of oxidative stress in obsessive compulsive disorder in response to treatment with Fluoxetine
Sutirtha Chakraborty, Anindya Dasgupta, Harendra Nath Das, Om Prakash Singh, Asok Kumar Mandal, Nikhiles Mandal
Indian Journal of Clinical Biochemistry. 2009; 24(2): 194
[HTML Full text]  [Google Scholar] [DOI]